Josh Davids

Account Registration

Already a member?

"*" indicates required fields

Step 1 of 3

Username

Name

Password*

Strength indicator

Recommendations: at least 12 characters in length, include a mix of character types (uppercase, lowercase, numbers, special characters %$^&), do not use common words or phrases

Organization

Occupation Category*

Address

This field is hidden when viewing the form

occupational_category_audience_kdm

This field is hidden when viewing the form

occupational_category_audience_kdm

Want to Read more?

To view this content, please sign up or log in to your account.
Create an account in seconds or log in if you’re already a member.

Josh Davids

Recent Resources

Research That Matters – Extended-Release vs. Sublingual Buprenorphine in Actively Using Patients

Research That Matters – Long-Acting Injectable Buprenorphine for Opioid Use Disorder

Overdoses Are Up, But Do We Really Need Just More Residential Beds?

Transforming The SUD Treatment System: The Shatterproof Treatment Atlas Case Study

Josh Davids

Recent Resources

Research That Matters – Extended-Release vs. Sublingual Buprenorphine in Actively Using Patients

Research That Matters – Long-Acting Injectable Buprenorphine for Opioid Use Disorder

Overdoses Are Up, But Do We Really Need Just More Residential Beds?

Transforming The SUD Treatment System: The Shatterproof Treatment Atlas Case Study

Related

Simon Fredrick

Jill Anderson